NCT05106465View on ClinicalTrials.gov

A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions
Multiple Sclerosis (MS)
Interventions
DEVICE

Konectom platform

Administered as specified in the treatment arm.

Trial Locations (1)

01307

Multiple Sclerosis Centre, Dresden

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT05106465 - A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage | Biotech Hunter | Biotech Hunter